Dr. Muhammad Saleh Faisal
PIMC, Peshawar
ANTI-AMOEBIC DRUGS
Amoebiasis is an acute or chronic infection caused by
Entamoeba histolytica.
Occurs due to ingestion of their cysts.
The parasite exist in two form:
 Trophozoites or active form: does not persist outside the
body.
 Cyst or inactive form: can survive outside the body &
labile.
Outcomes:
The outcome infection is variable.
 Asymptomatic but excrete the infectious cyst form,
making them a source for further infections.
 Amebic dysentery :
Trophozoites invade into the colonic mucosa with resulting
colitis and bloody diarrhea .
 Amebic liver abscess:
Trophozoites invade through the colonic mucosa, reach the
portal circulation, and travel to the liver and cause liver
abscess.
CLASSFICATION
Tissue Amoebicidals
Both intestinal & extra intestinal
 Nitroimidazoles – Metronidazole, Tinidazole, Secnidazole, Ornidazole
 Alkaloids - Emetine, Dehydroemetine
Extra intestinal amoebiasis only - Chloroquine
Luminal Amoebicidals
 Amide –Diloxanide furoate
 8-Hydroxy quinolones –Iodoquinol
 Antibiotics – Tetracycline, Paromomycin
TISSUE AMOEBICIDALS
Pharmacokinetics:
 Well absorbed after oral administration
 Distributed in sufficient concentration in the liver, gut,
pelvic tissues, CNS, lungs & other tissues. Reaches high
concentration in body fluids including CSF
 Metabolized by oxidation & glucoronide conjugation in
the liver
 It is eliminated mainly by the kidney
 Plasma protein binding is low (<20%)
 T½ = 8 hours
Metronidazole
Spectrum:
Bactericidal against :
 Entamoeba histolytica, Giardia lamblia, trachoma vaginalis
 Anaerobic bacteria - Anaerobic Streptococci, Bacteroide
fragilis, Clostridium perfringes/difficile, Fusobacterium,,
Helicobacter pylori
 Does not affect aerobic bacteria.
Mechanism of action
 Metronidazole is a pro-drug.
 Susceptible microorganisms including anaerobic bacteria &
certain protozoa reduces the nitro group of metronidazole by
(PFOR) pyruvate ferredoxin oxido-reductase also known as
nitro-reductase & convert it to active cytotoxic derivative
which binds covalently to DNA, disrupts its helical structure
and thus preventing bacterial nucleic acid synthesis = death.
 Aerobic bacteria lacks this nitro-reductase & are therefore
not susceptible to metronidazole
Clinical Indications:
 All symptomatic forms of amoebiasis
 Giardiasis
 Trichomoniasis of urogenital tract in both genders
 Balantidiasis
 Most of Anaerobic infections (clostridial)
 Pseudomembranous colitis
 Helicobacter pylori
 Acute ulcerative gingivitis
 Acute dental infection
 Osteomyelitis
 Abscess of brain & lungs
 Prophylaxis of endocarditis by bacillus fragilis
 Prophylaxis of post-surgical abdominal & pelvic
infection
 Treatment of sepsis: post surgical infection, intra-
abdominal infection & septicemia
Toxicities:
 Common: Dry mouth, metallic taste, stomatitis, nausea,
headache
 Occasional: vomiting, diarrhea, abdominal distress
 Rare: Urticaria, Flushing, Pruritis
 Serious CNS toxicities warrant discontinuation:
Encephalopathy, Ataxia, vertigo, Dizziness, Convulsion,
Incoordination.
 Disulfiram like reaction:
In alcoholic patient:
o Due to inhibition of Acetyldehyde dehydrogenase
enzyme = Acetyldehyde = severe hang over
↑
o Symptom: throbbing headache, visual disturbance,
shortness of breath, nausea, vomiting, Flushing of
the skin, palpatataions, circulatory collapse.
o So to avoid, should not take 12 hours after alcohol
consumption.
Tinidazole
 long t ½ , slower metabolism, long DOA= OD dosing.
 Higher cure rates in amoebiasis.
 Lower ADR metallic taste ,nausea, rash.
USES
 Amoebiasis (2g od ---- 3 days)
 Trichomoniasis, giardiasis (2g od ---- single dose)
 Anaerobic infections:
 Px - 2 g od ---- single dose (for colorectal surgeries)
 Tx – 500 mg bd ---- 5 days
 H pylori (500 mg bd ---- 2 wks in triple therapy)
Ornidazole
 long t ½
 similar to Tinidazole
Secnidazole
 longest t ½ [17-29 hrs]
 For intestinal amoebiasis = 2 g - od - single dose
 But for hepatic amoebiasis = 1.5 gm - od - 5 days
 Emetine, an alkaloid derived from ipecac
 Dehydroemetine, a synthetic analog
 Active against tissue trophozoites
 No action on cysts
MOA
Inhibiting peptidyl-tRNA translocation → inhibiting
elongation of peptide chain → inhibiting protein synthesis
→ interfering cleavage and breeding of trophozoites
Emetin & Dehydroemetine
Uses:
 Both are effective against tissue trophozoites of E histolytica, but
because of its major ADR they have been almost completely replaced
by metronidazole.
 Use in circumstances where severe amebiasis warrants effective
therapy and metronidazole cannot be used.
 Dehydroemetine is preferred because of its somewhat better toxicity
profile.
 Should be used for the minimum period to relieve severe symptoms
(usually 3–5 days).
Routes of administration:
SC or IM in a supervised setting.
Adverse effect:
 Pain and tenderness in the area of injection are frequent
and sterile abscesses may develop.
 Serious toxicities include cardiac arrhythmias, heart
failure, and hypotension
 Muscle weakness due to neuromuscular blockage.
 Diarrhea, Nausea, vomiting and abdominal discomfort
Chloroquine
 Because of complete absorption from Small gut, much
lower concentration in gut wall so less effect on luminal
ameobas.
 Effective in Hepatic amoebiasis bcz concentrated in liver
 Use only when metronidazole is not effective or
contraindicated. Highly effective when combine with
emetine/ dehydroemetine
Dose
• Adults 1g/day x 02 days then 500mg/day x 02 weeks
LUMINAL AMOEBICIDALS
Diloxanide furoate
 A dichloroacetamide derivative.
 It is an effective luminal amebicide but is not active
against tissue trophozoites.
 It is used with a tissue amebicide, usually metronidazole,
to treat serious intestinal and extraintestinal infections.
 In the gut, diloxanide furoate is split into diloxanide and
furoic acid. Diloxanide is absorbed but has got no
amoebicidal activity. The unabsorbed diloxanide is the
active antiamebic substance.
Mechanism of action
is unknown.
Adverse effects:
 Diloxanide furoate does not produce serious adverse
effects.
 Flatulence is common.
 Sometimes nausea and abdominal cramps and rashes are
seen.
Iodoquinol
It is effective against organisms in the bowel lumen.
Not useful against trophozoites in the intestinal wall or
extraintestinal tissue.
Pharmacokinetics:
 Pk profile is Poorly understood
 90% of the drug is retained in the intestine & excreted in
the feces.
 The remainder enters the circulation and has a t½ of 11-
14 hours which later excreted in the urine.
Mechanism of action:
Unknown
Adverse effects:
Anorexia, nausea, vomiting, abdominal pain.
Headache, rash & pruritus
Contra-indications:
 It should be carefully used in patients with thyroid problems
because the drug may increase serum iodine by displacing
from protein bound.
 It is contraindicated in patients with intolerance to iodine
Paromomycin sulfate
 An aminoglycoside antibiotic that is not significantly absorbed from
the GIT
 It is used only as a luminal amebicide.
 No effect against extraintestinal amoebic infections
 In a recent study, it was superior to diloxanide furoate in clearing
asymptomatic infections.
MOA:
 Inhibits protein synthesis → kill trophozoites.
 Also, inhibits the bacterial flora with which Entamoebae live
symbiotically.
Adverse effects:
Tetracyclines
 Older tetracyclines are incompletely absorbed in the small
intestine, reach the colon in large amounts and inhibit the
bacterial flora with which Entamoebae live symbiotically.
Thus, they indirectly reduce proliferation of
entamoebae in the colon.
 At high conc, directly inhibit amoebae.
Asymptomatic cyst passers
 DOC= Diloxanide furoate
 A paromomycin or tetracycline with tissue amoebicide
in cases which fail to clear completely.
SUMMARY OF AMOEBIASIS TREATMENT
Invasive intestinal amoebiasis
 DOC= Metronidazole/ Tinidazole
 Alternatives= Secnidazole, ornidazole,satranidazole
 Symptomatic measures for diarrhea and abdominal pain.
Hepatic amoebiasis
 Complete eradication of trophozoites from the liver is
essential to avoid relapses.
 Abscess  aspirated.
 DOC= Metronidazole / Tinidazole
 Dehydroemetine is to be used only if metronidazole
cannot be given for one reason or the other.
 Addional luminal amoebicide must be given later to
finish the intestinal reservoir of infection.
THANK YOU

7. Anti-amoebic drugs.pptx treatment for ameobic dycentry

  • 1.
    Dr. Muhammad SalehFaisal PIMC, Peshawar ANTI-AMOEBIC DRUGS
  • 2.
    Amoebiasis is anacute or chronic infection caused by Entamoeba histolytica. Occurs due to ingestion of their cysts. The parasite exist in two form:  Trophozoites or active form: does not persist outside the body.  Cyst or inactive form: can survive outside the body & labile.
  • 4.
    Outcomes: The outcome infectionis variable.  Asymptomatic but excrete the infectious cyst form, making them a source for further infections.  Amebic dysentery : Trophozoites invade into the colonic mucosa with resulting colitis and bloody diarrhea .  Amebic liver abscess: Trophozoites invade through the colonic mucosa, reach the portal circulation, and travel to the liver and cause liver abscess.
  • 5.
    CLASSFICATION Tissue Amoebicidals Both intestinal& extra intestinal  Nitroimidazoles – Metronidazole, Tinidazole, Secnidazole, Ornidazole  Alkaloids - Emetine, Dehydroemetine Extra intestinal amoebiasis only - Chloroquine Luminal Amoebicidals  Amide –Diloxanide furoate  8-Hydroxy quinolones –Iodoquinol  Antibiotics – Tetracycline, Paromomycin
  • 6.
  • 7.
    Pharmacokinetics:  Well absorbedafter oral administration  Distributed in sufficient concentration in the liver, gut, pelvic tissues, CNS, lungs & other tissues. Reaches high concentration in body fluids including CSF  Metabolized by oxidation & glucoronide conjugation in the liver  It is eliminated mainly by the kidney  Plasma protein binding is low (<20%)  T½ = 8 hours Metronidazole
  • 8.
    Spectrum: Bactericidal against : Entamoeba histolytica, Giardia lamblia, trachoma vaginalis  Anaerobic bacteria - Anaerobic Streptococci, Bacteroide fragilis, Clostridium perfringes/difficile, Fusobacterium,, Helicobacter pylori  Does not affect aerobic bacteria.
  • 9.
    Mechanism of action Metronidazole is a pro-drug.  Susceptible microorganisms including anaerobic bacteria & certain protozoa reduces the nitro group of metronidazole by (PFOR) pyruvate ferredoxin oxido-reductase also known as nitro-reductase & convert it to active cytotoxic derivative which binds covalently to DNA, disrupts its helical structure and thus preventing bacterial nucleic acid synthesis = death.  Aerobic bacteria lacks this nitro-reductase & are therefore not susceptible to metronidazole
  • 10.
    Clinical Indications:  Allsymptomatic forms of amoebiasis  Giardiasis  Trichomoniasis of urogenital tract in both genders  Balantidiasis  Most of Anaerobic infections (clostridial)  Pseudomembranous colitis  Helicobacter pylori  Acute ulcerative gingivitis  Acute dental infection  Osteomyelitis  Abscess of brain & lungs
  • 11.
     Prophylaxis ofendocarditis by bacillus fragilis  Prophylaxis of post-surgical abdominal & pelvic infection  Treatment of sepsis: post surgical infection, intra- abdominal infection & septicemia
  • 12.
    Toxicities:  Common: Drymouth, metallic taste, stomatitis, nausea, headache  Occasional: vomiting, diarrhea, abdominal distress  Rare: Urticaria, Flushing, Pruritis  Serious CNS toxicities warrant discontinuation: Encephalopathy, Ataxia, vertigo, Dizziness, Convulsion, Incoordination.
  • 13.
     Disulfiram likereaction: In alcoholic patient: o Due to inhibition of Acetyldehyde dehydrogenase enzyme = Acetyldehyde = severe hang over ↑ o Symptom: throbbing headache, visual disturbance, shortness of breath, nausea, vomiting, Flushing of the skin, palpatataions, circulatory collapse. o So to avoid, should not take 12 hours after alcohol consumption.
  • 14.
    Tinidazole  long t½ , slower metabolism, long DOA= OD dosing.  Higher cure rates in amoebiasis.  Lower ADR metallic taste ,nausea, rash. USES  Amoebiasis (2g od ---- 3 days)  Trichomoniasis, giardiasis (2g od ---- single dose)  Anaerobic infections:  Px - 2 g od ---- single dose (for colorectal surgeries)  Tx – 500 mg bd ---- 5 days  H pylori (500 mg bd ---- 2 wks in triple therapy)
  • 15.
    Ornidazole  long t½  similar to Tinidazole Secnidazole  longest t ½ [17-29 hrs]  For intestinal amoebiasis = 2 g - od - single dose  But for hepatic amoebiasis = 1.5 gm - od - 5 days
  • 16.
     Emetine, analkaloid derived from ipecac  Dehydroemetine, a synthetic analog  Active against tissue trophozoites  No action on cysts MOA Inhibiting peptidyl-tRNA translocation → inhibiting elongation of peptide chain → inhibiting protein synthesis → interfering cleavage and breeding of trophozoites Emetin & Dehydroemetine
  • 17.
    Uses:  Both areeffective against tissue trophozoites of E histolytica, but because of its major ADR they have been almost completely replaced by metronidazole.  Use in circumstances where severe amebiasis warrants effective therapy and metronidazole cannot be used.  Dehydroemetine is preferred because of its somewhat better toxicity profile.  Should be used for the minimum period to relieve severe symptoms (usually 3–5 days).
  • 18.
    Routes of administration: SCor IM in a supervised setting. Adverse effect:  Pain and tenderness in the area of injection are frequent and sterile abscesses may develop.  Serious toxicities include cardiac arrhythmias, heart failure, and hypotension  Muscle weakness due to neuromuscular blockage.  Diarrhea, Nausea, vomiting and abdominal discomfort
  • 19.
    Chloroquine  Because ofcomplete absorption from Small gut, much lower concentration in gut wall so less effect on luminal ameobas.  Effective in Hepatic amoebiasis bcz concentrated in liver  Use only when metronidazole is not effective or contraindicated. Highly effective when combine with emetine/ dehydroemetine Dose • Adults 1g/day x 02 days then 500mg/day x 02 weeks
  • 20.
  • 21.
    Diloxanide furoate  Adichloroacetamide derivative.  It is an effective luminal amebicide but is not active against tissue trophozoites.  It is used with a tissue amebicide, usually metronidazole, to treat serious intestinal and extraintestinal infections.  In the gut, diloxanide furoate is split into diloxanide and furoic acid. Diloxanide is absorbed but has got no amoebicidal activity. The unabsorbed diloxanide is the active antiamebic substance.
  • 22.
    Mechanism of action isunknown. Adverse effects:  Diloxanide furoate does not produce serious adverse effects.  Flatulence is common.  Sometimes nausea and abdominal cramps and rashes are seen.
  • 23.
    Iodoquinol It is effectiveagainst organisms in the bowel lumen. Not useful against trophozoites in the intestinal wall or extraintestinal tissue. Pharmacokinetics:  Pk profile is Poorly understood  90% of the drug is retained in the intestine & excreted in the feces.  The remainder enters the circulation and has a t½ of 11- 14 hours which later excreted in the urine.
  • 24.
    Mechanism of action: Unknown Adverseeffects: Anorexia, nausea, vomiting, abdominal pain. Headache, rash & pruritus Contra-indications:  It should be carefully used in patients with thyroid problems because the drug may increase serum iodine by displacing from protein bound.  It is contraindicated in patients with intolerance to iodine
  • 25.
    Paromomycin sulfate  Anaminoglycoside antibiotic that is not significantly absorbed from the GIT  It is used only as a luminal amebicide.  No effect against extraintestinal amoebic infections  In a recent study, it was superior to diloxanide furoate in clearing asymptomatic infections. MOA:  Inhibits protein synthesis → kill trophozoites.  Also, inhibits the bacterial flora with which Entamoebae live symbiotically. Adverse effects:
  • 26.
    Tetracyclines  Older tetracyclinesare incompletely absorbed in the small intestine, reach the colon in large amounts and inhibit the bacterial flora with which Entamoebae live symbiotically. Thus, they indirectly reduce proliferation of entamoebae in the colon.  At high conc, directly inhibit amoebae.
  • 27.
    Asymptomatic cyst passers DOC= Diloxanide furoate  A paromomycin or tetracycline with tissue amoebicide in cases which fail to clear completely. SUMMARY OF AMOEBIASIS TREATMENT
  • 28.
    Invasive intestinal amoebiasis DOC= Metronidazole/ Tinidazole  Alternatives= Secnidazole, ornidazole,satranidazole  Symptomatic measures for diarrhea and abdominal pain.
  • 29.
    Hepatic amoebiasis  Completeeradication of trophozoites from the liver is essential to avoid relapses.  Abscess  aspirated.  DOC= Metronidazole / Tinidazole  Dehydroemetine is to be used only if metronidazole cannot be given for one reason or the other.  Addional luminal amoebicide must be given later to finish the intestinal reservoir of infection.
  • 30.

Editor's Notes

  • #3 Ingestion of cysts Cysts are ingested through feces, contaminated food or water. Formation of trophozoites Cysts are passed into the lumen of intestine, where the trophozoites are liberated. Penetration and multiplication of trophozoites Trophozoites are penetrated in intestinal wall and multiply within colon wall. They either invade and ulcerate the mucosa of large intestine or simply feed on intestinal bacteria. Systemic invasion Large numbers of trophozoites within the colon wall can also lead to systemic invasion and caused liver abscess. Cysts discarded The trophozoites within the intestine are slowly carried toward the rectum, where they return to cyst form and are excreted in feces.
  • #10 Giardiasis =dysentery by giardia lamblia Trichomoniasis= std by trichomonas vaginalis Balantidiasis= inf by balantidium coli Psudomembranous colitis= inlamation of colon by clostridium deficile
  • #13 Disulfiraum is used in cocaine dependence as it inhibit Dopa decarboxylase → Prevent breakdown of dopamine. ( A NT whose release is stimulated by cocaine) The excess dopamine results in increase anxiety, high BP, restlessness.